These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 26552645)

  • 21. Familial Dok7 congenital myasthenic syndrome responsive to salbutamol.
    Maramattom BV; Patil R; Thomas J
    Neurol India; 2014; 62(3):313. PubMed ID: 25033858
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome.
    Witting N; Vissing J
    JAMA Neurol; 2014 Mar; 71(3):350-4. PubMed ID: 24425145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
    Cossins J; Liu WW; Belaya K; Maxwell S; Oldridge M; Lester T; Robb S; Beeson D
    Hum Mol Genet; 2012 Sep; 21(17):3765-75. PubMed ID: 22661499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DOK7 congenital myasthenic syndrome responsive to oral salbutamol.
    Tayade K; Salunkhe M; Agarwal A; Radhakrishnan DM; Srivastava AK
    QJM; 2022 May; 115(5):323-324. PubMed ID: 35092298
    [No Abstract]   [Full Text] [Related]  

  • 25. DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children.
    Klein A; Pitt MC; McHugh JC; Niks EH; Sewry CA; Phadke R; Feng L; Manzur AY; Tirupathi S; Devile C; Jayawant S; Finlayson S; Palace J; Muntoni F; Beeson D; Robb SA
    Neuromuscul Disord; 2013 Nov; 23(11):883-91. PubMed ID: 23831158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7.
    Ben Ammar A; Petit F; Alexandri N; Gaudon K; Bauché S; Rouche A; Gras D; Fournier E; Koenig J; Stojkovic T; Lacour A; Petiot P; Zagnoli F; Viollet L; Pellegrini N; Orlikowski D; Lazaro L; Ferrer X; Stoltenburg G; Paturneau-Jouas M; Hentati F; Fardeau M; Sternberg D; Hantaï D; Richard P; Eymard B
    J Neurol; 2010 May; 257(5):754-66. PubMed ID: 20012313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
    McMacken GM; Spendiff S; Whittaker RG; O'Connor E; Howarth RM; Boczonadi V; Horvath R; Slater CR; Lochmüller H
    Hum Mol Genet; 2019 Jul; 28(14):2339-2351. PubMed ID: 31220253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variable phenotypes associated with mutations in DOK7.
    Anderson JA; Ng JJ; Bowe C; McDonald C; Richman DP; Wollmann RL; Maselli RA
    Muscle Nerve; 2008 Apr; 37(4):448-56. PubMed ID: 18161030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A late-onset congenital myasthenic syndrome due to a heterozygous DOK7 mutation.
    Bastos P; Barbosa R; Fernandes M; Alonso I
    Neuromuscul Disord; 2020 Apr; 30(4):331-335. PubMed ID: 32360404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment.
    Webster RG; Cossins J; Lashley D; Maxwell S; Liu WW; Wickens JR; Martinez-Martinez P; de Baets M; Beeson D
    Exp Neurol; 2013 Oct; 248():286-98. PubMed ID: 23797154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dok-7/MuSK signaling and a congenital myasthenic syndrome.
    Yamanashi Y; Higuch O; Beeson D
    Acta Myol; 2008 Jul; 27(1):25-9. PubMed ID: 19108574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders.
    Clausen L; Cossins J; Beeson D
    J Neuromuscul Dis; 2018; 5(2):231-240. PubMed ID: 29865088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic dysfunction in congenital myasthenic syndromes.
    Beeson D
    Ann N Y Acad Sci; 2012 Dec; 1275():63-9. PubMed ID: 23278579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
    Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital Myasthenic Syndrome Caused by DOK7 Mutation in a Quinquagenarian Male with Calf Hypertrophy.
    Gomathy SB; Das A; Garg A; Srivastava AK
    J Clin Neuromuscul Dis; 2023 Sep; 25(1):51-54. PubMed ID: 37611271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital myasthenic syndrome in China: genetic and myopathological characterization.
    Zhao Y; Li Y; Bian Y; Yao S; Liu P; Yu M; Zhang W; Wang Z; Yuan Y
    Ann Clin Transl Neurol; 2021 Apr; 8(4):898-907. PubMed ID: 33756069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.
    Guergueltcheva V; Müller JS; Dusl M; Senderek J; Oldfors A; Lindbergh C; Maxwell S; Colomer J; Mallebrera CJ; Nascimento A; Vilchez JJ; Muelas N; Kirschner J; Nafissi S; Kariminejad A; Nilipour Y; Bozorgmehr B; Najmabadi H; Rodolico C; Sieb JP; Schlotter B; Schoser B; Herrmann R; Voit T; Steinlein OK; Najafi A; Urtizberea A; Soler DM; Muntoni F; Hanna MG; Chaouch A; Straub V; Bushby K; Palace J; Beeson D; Abicht A; Lochmüller H
    J Neurol; 2012 May; 259(5):838-50. PubMed ID: 21975507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
    Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
    Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COLQ-Related Congenital Myasthenic Syndrome and Response to Salbutamol Therapy.
    Padmanabha H; Saini AG; Sankhyan N; Singhi P
    J Clin Neuromuscul Dis; 2017 Mar; 18(3):162-163. PubMed ID: 28221310
    [No Abstract]   [Full Text] [Related]  

  • 40. Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
    Kinali M; Beeson D; Pitt MC; Jungbluth H; Simonds AK; Aloysius A; Cockerill H; Davis T; Palace J; Manzur AY; Jimenez-Mallebrera C; Sewry C; Muntoni F; Robb SA
    J Neuroimmunol; 2008 Sep; 201-202():6-12. PubMed ID: 18707767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.